Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination
Lorenza Bellusci, Gabrielle Grubbs, Fatema Tuz Zahra, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
Bernadeta Dadonaite, Katharine H. D. Crawford, Caelan E. Radford, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1263-1278.e20
Open Access | Times Cited: 136
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 53
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Effectiveness of mass vaccination for prevention of hospitalization, severe disease and death due to SARS-CoV-2 omicron Ba.2 variant; a case- population study
Hamid Reza Shamsollahi, Sobhan Younesian, Ali Nikfarjam, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42670-e42670
Open Access
Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic
Smaranika Rahman, Md. Jamal Hossain, Zabun Nahar, et al.
Environmental Health Insights (2022) Vol. 16
Open Access | Times Cited: 24
Recent Advances of Representative Optical Biosensors for Rapid and Sensitive Diagnostics of SARS-CoV-2
Meimei Xu, Yanyan Li, Chenglong Lin, et al.
Biosensors (2022) Vol. 12, Iss. 10, pp. 862-862
Open Access | Times Cited: 23
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
Toon Braeye, Joris Adriaan Frank van Loenhout, Ruben Brondeel, et al.
Eurosurveillance (2023) Vol. 28, Iss. 26
Open Access | Times Cited: 11
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
Jennifer Serwanga, Claire Baine, Susan Mugaba, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
Kevin J. Selva, Pradhipa Ramanathan, Ebene R. Haycroft, et al.
JCI Insight (2023) Vol. 8, Iss. 18
Open Access | Times Cited: 10
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
Myeongsang Lee, Marian Major, Huixiao Hong
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3774-3774
Open Access | Times Cited: 9
High-resolution kinetics and cellular determinants of antibody response to SARS-CoV-2 over two years after COVID-19 vaccination
Carlota Dobaño, Rocío Rubio, Dídac Macià, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Large-scale validation of a plasmonic sensor for SARS-CoV-2 pseudo-neutralization with a cohort of food and retail workers
Julien Coutu, Pierre Ricard, Abdelhadi Djaïleb, et al.
Sensors & Diagnostics (2024) Vol. 3, Iss. 5, pp. 850-862
Open Access | Times Cited: 2
Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations
Dicle Yalcin, Sydney J. Bennett, Jared Sheehan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7292-7292
Open Access | Times Cited: 7
Emergent variant modeling of the serological repertoire to norovirus in young children
Lisa C. Lindesmith, Paul D. Brewer-Jensen, Helen Conrad, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100954-100954
Open Access | Times Cited: 6
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
Bernadeta Dadonaite, Katharine H. D. Crawford, Caelan E. Radford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets
Alexandre E. Nowill, Manuel Caruso, Pedro O. de Campos‐Lima
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Is a booster dose of COVID-19 vaccines effective on newly dominant omicron subvariants among university students? Comparison between BA.1 and BA.2 dominancy
Shunsuke Miyauchi, Toru Hiyama, Yukiko Nakano, et al.
American Journal of Infection Control (2022) Vol. 51, Iss. 8, pp. 907-911
Open Access | Times Cited: 9
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy
Ashley J. Priddey, Michael Chen‐Xu, Daniel J Cooper, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection
Sergey V. Kulemzin, Sergey V. Guselnikov, Boris G. Nekrasov, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 55-55
Open Access | Times Cited: 1
The impact of vaccination frequency on COVID-19 public health outcomes: A model-based analysis
Madison Stoddard, Yuan Lin, Sharanya Sarkar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination
Ching‐Fen Shen, Yi-Chen Fu, Tzong‐Shiann Ho, et al.
Clinical Immunology (2023) Vol. 251, pp. 109342-109342
Open Access | Times Cited: 4
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Lorenza Bellusci, Gabrielle Grubbs, Shaimaa Sait, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets
Zhihua Zheng, Xiushen Li, Kechao Nie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
Latha Dulipsingh, Ernst J. Schaefer, Dorothy Wakefield, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17410-e17410
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top